Buy Torrent Pharmaceuticals; target of Rs 2982: Geojit

Geojit is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2982 in its research report dated October 29, 2020.

Buy Torrent Pharmaceuticals; target of Rs 3135: ICICI Direct

ICICI Direct is bullish on Torrent Pharmaceuticals recommended buy rating on the stock with a target price of Rs 3135 in its research report dated October 27, 2020.

Torrent Pharma Standalone September 2020 Net Sales at Rs 1,640.00 crore, up 2.31% Y-o-Y

Hold Torrent Pharmaceuticals; target of Rs 2871: Sharekhan

Sharekhan recommended Hold rating on Torrent Pharmaceuticals with a target price of Rs 2871 in its research report dated October 26, 2020.

Torrent Pharma Standalone September 2020 Net Sales at Rs 1,640.00 crore, up 2.31% Y-o-Y

Torrent Pharmaceuticals Q2 net profit up 27% at Rs 310 crore

The company had posted a net profit of Rs 244 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to BSE.

Hold Torrent Pharmaceuticals; target of Rs 2780: Sharekhan

Sharekhan recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 2780 in its research report dated July 30, 2020.

Buy Torrent Pharmaceuticals; target of Rs 2865: ICICI Direct

ICICI Direct is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2865 in its research report dated July 31, 2020.

Torrent Pharma Standalone June 2020 Net Sales at Rs 1,727.00 crore, up 7.74% Y-o-Y

Torrent Pharma Consolidated June 2020 Net Sales at Rs 2,056.00 crore, up 1.68% Y-o-Y

Hold Torrent Pharmaceuticals; target of Rs 2574: ICICI Securities

ICICI Securities recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 2574 in its research report dated May 27, 2020.

Hold Torrent Pharmaceuticals; target of Rs 2475: ICICI Direct

ICICI Direct recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 2475 in its research report dated May 27, 2020.

Torrent Pharma Standalone March 2020 Net Sales at Rs 1,491.00 crore, up 9.87% Y-o-Y

Torrent Pharma Consolidated March 2020 Net Sales at Rs 1,946.00 crore, up 4.85% Y-o-Y

Torrent Pharma posts net profit of Rs 314 crore for March quarter

The company posted Rs 7,939 crore as revenue from operations for the fiscal year ended March 2020. It was Rs 7,673 crore for the year-ago fiscal year, it added.

Torrent Pharma says promoters haven't pledged shares

The promoters are obligated to hold a minimum 26 per cent shares and management control of Torrent Pharma during the period of loans the company has taken, it said.

NSE identifies five companies for surveillance action

In addition, the exchange has dropped six companies from surveillance action category for having higher levels of pledged shares by promoters.

Torrent Pharma gets shareholder nod to raise up to Rs 5,000cr

In a filing to the BSE, the company said around 99.299 per cent votes were cast in favour of "issuance of equity shares including convertible bonds/debentures through QIP and/or depository receipts or any other modes for an amount not exceeding Rs 5,000 crore."

Torrent Pharma Standalone December 2019 Net Sales at Rs 1,471.00 crore, down 0.68% Y-o-Y

Torrent Pharma Standalone December 2019 Net Sales at Rs 1,471.00 crore, down 0.68% Y-o-Y

Torrent Pharma Consolidated December 2019 Net Sales at Rs 1,966.00 crore, down 4.14% Y-o-Y

Torrent Pharma Q3 net profit up 2% at Rs 251cr

The company had posted a net profit of Rs 246 crore for the corresponding period previous fiscal, Torrent Pharmaceuticals said in a BSE filing.

Torrent Pharma to consider fund raising on Jan 27; share price hits 52-week high

The company has fixed February 4 as the record date for the purpose of payment of interim dividend

USFDA red flags Torrent Pharma's US-based plant for manufacturing violations

The USFDA inspected the plant from March 11 to April 9 this year.

Hold Torrent Pharmaceuticals; target of Rs 1720: Sharekhan

Sharekhan recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1720 in its research report dated October 23, 2019.